PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.59M (Avg.)
37.59 | 5.48
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-80.96%
Both yoy net incomes decline, with MCHP at -4.33%. Martin Whitman would view it as a broader sector or cyclical slump hitting profits.
12.69%
Some D&A expansion while MCHP is negative at -0.43%. John Neff would see competitor’s short-term profit advantage unless expansions here deliver big returns.
70.51%
Lower deferred tax growth vs. MCHP's 235.24%, implying fewer future tax liabilities. David Dodd would confirm there’s no short-term tax shock instead.
No Data
No Data available this quarter, please select a different quarter.
171.65%
Slight usage while MCHP is negative at -244.57%. John Neff would note competitor possibly capturing more free cash unless expansions are needed here.
No Data
No Data available this quarter, please select a different quarter.
163.16%
Inventory shrinking or stable vs. MCHP's 2456.52%, indicating lean supply management. David Dodd would confirm no demand shortfall.
No Data
No Data available this quarter, please select a different quarter.
175.28%
Some yoy usage while MCHP is negative at -247.97%. John Neff would see competitor possibly generating more free cash from minor accounts than we do.
-5.56%
Both negative yoy, with MCHP at -127.24%. Martin Whitman would suspect an overall environment of intangible cleanup or shifting revaluations for the niche.
6.27%
Some CFO growth while MCHP is negative at -34.01%. John Neff would note a short-term liquidity lead over the competitor.
60.91%
Some CapEx rise while MCHP is negative at -75.93%. John Neff would see competitor possibly building capacity while we hold back expansions.
No Data
No Data available this quarter, please select a different quarter.
-46066.67%
Both yoy lines negative, with MCHP at -204.58%. Martin Whitman would suspect an environment with fewer attractive securities or a strategic pivot to internal growth.
133.33%
Proceeds from sales/maturities above 1.5x MCHP's 4.09%. David Dodd would confirm if the firm is capitalizing on strong valuations or freeing liquidity for expansions.
No Data
No Data available this quarter, please select a different quarter.
-969.75%
Both yoy lines negative, with MCHP at -180.29%. Martin Whitman suspects a broader cyclical shift away from heavy investing across the niche.
No Data
No Data available this quarter, please select a different quarter.
-50.00%
Negative yoy issuance while MCHP is 0.00%. Joel Greenblatt sees a near-term advantage in avoiding dilution unless competitor invests more effectively with the new shares.
10.02%
Buyback growth below 50% of MCHP's 78.73%. Michael Burry suspects fewer capital returns to shareholders vs. competitor, unless expansions hold higher ROI.